Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Fostering innovation, advancing patient safety: the kidney health initiative.

Archdeacon P, Shaffer RN, Winkelmayer WC, Falk RJ, Roy-Chaudhury P.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1609-17. doi: 10.2215/CJN.01140113. Epub 2013 Jun 6.

2.

Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.

Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, Welebob E, Scarnecchia T, Woodcock J.

Ann Intern Med. 2010 Nov 2;153(9):600-6. doi: 10.7326/0003-4819-153-9-201011020-00010.

PMID:
21041580
3.

Achieving a transparent, actionable framework for public-private partnerships for food and nutrition research.

Alexander N, Rowe S, Brackett RE, Burton-Freeman B, Hentges EJ, Kretser A, Klurfeld DM, Meyers LD, Mukherjea R, Ohlhorst S.

Am J Clin Nutr. 2015 Jun;101(6):1359-63. doi: 10.3945/ajcn.115.112805.

4.

Catalyzing the Critical Path Initiative: FDA's progress in drug development activities.

Parekh A, Buckman-Garner S, McCune S, ONeill R, Geanacopoulos M, Amur S, Clingman C, Barratt R, Rocca M, Hills I, Woodcock J.

Clin Pharmacol Ther. 2015 Mar;97(3):221-33. doi: 10.1002/cpt.42. Epub 2015 Jan 28.

PMID:
25670629
5.

The PCAST report on pharmaceutical innovation: implications for the FDA.

Woodcock J.

Clin Pharmacol Ther. 2013 Sep;94(3):297-300. doi: 10.1038/clpt.2013.88.

PMID:
23963215
6.

Stimulating Patient Engagement in Medical Device Development in Kidney Disease: A Report of a Kidney Health Initiative Workshop.

Hurst FP, Chianchiano D, Upchurch L, Fisher BR, Flythe JE, Castillo Lee C, Hill T, Neuland CY.

Am J Kidney Dis. 2017 Oct;70(4):561-569. doi: 10.1053/j.ajkd.2017.03.013. Epub 2017 Apr 27.

PMID:
28457656
7.

Chronic kidney disease in the United States: a public policy imperative.

Rettig RA, Norris K, Nissenson AR.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1902-10. doi: 10.2215/CJN.02330508. Epub 2008 Oct 15.

8.

Glomerular Diseases: Registries and Clinical Trials.

Moxey-Mims MM, Flessner MF, Holzman L, Kaskel F, Sedor JR, Smoyer WE, Thompson AM, Yao L.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2234-2243. Epub 2016 Sep 26.

9.

Public-private partnerships: the evolving role of industry funding in nutrition research.

Zachwieja J, Hentges E, Hill JO, Black R, Vassileva M.

Adv Nutr. 2013 Sep 1;4(5):570-2. doi: 10.3945/an.113.004382.

10.

Public-private partnership scenario in the health care system of Pakistan.

Ahmed F, Nisar N.

East Mediterr Health J. 2010 Aug;16(8):910-2.

PMID:
21469575
11.

Lessons learned from independent central review.

Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.

Eur J Cancer. 2009 Jan;45(2):268-74. doi: 10.1016/j.ejca.2008.10.031.

PMID:
19101138
12.

FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access.

Hurst FP, Lee RE, Thompson AM, Pullin BD, Silverstein DM.

Clin J Am Soc Nephrol. 2017 Jul 24. pii: CJN.02900317. doi: 10.2215/CJN.02900317. [Epub ahead of print]

PMID:
28739575
13.

Origins of medical innovation: the case of coronary artery stents.

Xu S, Avorn J, Kesselheim AS.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):743-9. doi: 10.1161/CIRCOUTCOMES.112.967398. Epub 2012 Oct 23. Review.

14.

Collaborative initiatives: where the rubber meets the road in community partnerships.

Bazzoli GJ, Casey E, Alexander JA, Conrad DA, Shortell SM, Sofaer S, Hasnain-Wynia R, Zukoski AP.

Med Care Res Rev. 2003 Dec;60(4 Suppl):63S-94S.

PMID:
14687430
15.

How are drugs approved? Part 1: the evolution of the Food and Drug Administration.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2008 Jan;46(1):15-9. Review.

PMID:
18251347
16.

The innovative medicines initiative: a European response to the innovation challenge.

Goldman M.

Clin Pharmacol Ther. 2012 Mar;91(3):418-25. doi: 10.1038/clpt.2011.321. Epub 2012 Feb 8. Review.

PMID:
22318619
17.

Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration.

Perrone RD, Coons SJ, Cavanaugh K, Finkelstein F, Meyer KB.

Am J Kidney Dis. 2013 Dec;62(6):1046-57. doi: 10.1053/j.ajkd.2013.07.004. Epub 2013 Aug 26.

PMID:
23988757
18.

[Diagnostic kits in parasitology: which controls?].

Rossi P.

Parassitologia. 2004 Jun;46(1-2):145-9. Review. Italian.

PMID:
15305705
19.

The Clinical Trials Transformation Initiative (CTTI).

Grignolo A.

Ann Ist Super Sanita. 2011;47(1):14-8. doi: 10.4415/ANN_11_01_04. Review.

20.

Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.

Berdud I, Arenas MD, Bernat A, Ramos R, Blanco A; Grupo de Trabajo de Hemodiálisis Extrahospitalaria (Outpatient Haemodialysis Group).

Nefrologia. 2011;31(6):664-9. doi: 10.3265/Nefrologia.pre2011.Oct.11001. English, Spanish.

Supplemental Content

Support Center